GDP-L-Fuc:N-acetyl-β-D-glucosaminide α1-6-fucosyltransferase (α1-6FucT) catalyzes the
transfer of fucose from GDP-Fuc to N-linked type complex glycoproteins. This enzyme was …

Tumor suppressor p53 is a transcription factor that guards the genome stability and normal
cell growth. Stresses like DNA damage, oncogenic assault will turn on p53 function which …

Despite the critical need for iron in many cellular reactions, deletion of the transferrin pathway
does not block organogenesis, suggesting the presence of alternative methods to deliver …

COVID-19 has become a pandemic. The influence of meteorological factors on the transmission
and spread of COVID-19 is of interest. This study sought to examine the associations of …

p53 represents an ideal target for anti-cancer drug design, because p53 is mutated in more
than half of human tumors. Most of the remaining tumors, although carrying wild-type p53, …

p53-dependent apoptosis is a major determinant of its tumor suppressor activity and can be
triggered by hypoxia. No p53 target is known to be induced by p53 or to mediate p53-…

c-Myc stimulates angiogenesis in tumors through mechanisms that remain incompletely
understood. Recent work indicates that c-Myc upregulates the miR-17∼92 microRNA cluster …

Recombinant tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is an
antitumor protein that is in clinical trials as a potential anticancer therapy but suffers from drug …

Cells expressing oncogenic c-Myc are sensitized to TNF superfamily proteins. c-Myc also is
an important factor in determining whether a cell is sensitive to TRAIL-induced apoptosis, …

CP-31398, a styrylquinazoline, emerged from a high throughput screen for therapeutic
agents that restore a wild-type-associated epitope (monoclonal antibody 1620) on the DNA-…